Navigation Links
Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
Date:4/1/2008

BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it signed a letter of intent to begin establishing Heartcentrix(R) ECG connectivity with the Misys MyWay(TM) electronic medical record (EMR) system from Misys Healthcare.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Misys Healthcare serves more than 100,000 physicians in 18,000 practice locations. "Misys MyWay integrates EMR, practice management, and claims management to offer a simple, affordable, complete solution for physicians and clinicians," Paul Edge, Vice President, Clinical Solutions for Misys Healthcare said. "With this agreement, thousands of our customers have the potential to access information from new or currently installed Burdick and Quinton electrocardiograph (ECG) devices, stress systems, and Holter devices while using our Misys MyWay EMR systems."

The HeartCentrix solution from Cardiac Science helps bring patient history, clinical charting, e-prescribing, lab orders, results, and patient follow-up information together into a single EMR application. "We designed HeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman, senior marketing manager for Cardiac Science. "Ultimately, the patient benefits. With streamlined integration, physicians have easier access to information, faster results, and fewer chances for operator error, patients receive a higher standard of care."

Tony Titus, Cardiac Science vice president of marketing added, "The agreement with Misys Healthcare is another step in our goal to connect our diagnostic cardiology products seamlessly with all major EMR solution providers. We're very much looking forward to this partnership."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

About Misys Healthcare Systems, LLC

Misys Healthcare -- part of the global application software and services company, Misys plc (FTSE: MSY.L) -- delivers integrated, comprehensive solutions that improve results for healthcare practitioners. Drawing on our decades of healthcare experience, our relationships with more than 100,000 healthcare professionals, and our commitment to customer success, we deliver innovative software and services that enable physicians, caregivers, and a connected healthcare community. Misys Healthcare: Experience, Solutions, Results. Contact us today; visit http://www.misyshealthcare.com.

Forward Looking Statements

This press release contains forward-looking statements. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of Misys, as well as other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Company Contact: Investor Contact: Media Contact:

Mike Matysik Jenifer Kirtland Christopher Gale

Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.

Sr. Vice President and CFO (415) 896-6820 (201) 646-5431

(425) 402-2009 (203) 570-4681

cgale@evcgroup.com CSCX - G


'/>"/>
SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
2. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
3. New research shows that iPods do not interfere with cardiac pacemakers
4. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
5. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
6. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
7. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
8. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
9. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Thomson Scientific Begins Expansion of Web of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):